4/27/2023 0 Comments Novamind psychedelic stock![]() With this as a prerequisite, Novamind was an early mover in 2019 and made two strategic investments in industry-leading psychedelic retreats and clinics: Until such time that the FDA approves new psychedelic medicines, Novamind invests and operates exclusively in those jurisdictions with established legal regulations for the use of psychedelics. Novamind seeks to accelerate research and innovation in psychedelic medicine by investing in the people, science and technology required for a regulated psychedelics industry. Food and Drug Administration (“FDA”) are currently evaluating the safety and efficacy of MDMA-assisted psychotherapy (to treat PTSD) and psilocybin-assisted psychotherapy (to treat depression), and if approved, will require specialized infrastructure to facilitate patient treatment. Ongoing clinical trials approved by the U.S. Novamind was founded in May 2019 in Toronto, Canada. Novamind invests in the infrastructure that drives the world’s leading psychedelic clinics and retreats. Upon completion of the Qualifying Transaction and the Financing (as defined and described below), it is expected that Buzz Capital (following the Qualifying Transaction, the “ Resulting Issuer”) will be a Tier 2 Industrial Issuer, subject to Exchange approval. The proposed transaction is intended to constitute an arm’s length qualifying transaction (the " Qualifying Transaction") for Buzz Capital, as defined in Policy 2.4 of the Exchange. (TSXV: BUZ.P) (" Buzz Capital" or the " Corporation"), a capital pool company listed on the TSX Venture Exchange (the " Exchange"), is pleased to announce that it has signed a letter of intent dated (the " Letter of Intent") with Novamind Ventures Inc., an Ontario corporation, (" Novamind”) to complete a business combination by way of a transaction that will constitute a reverse takeover of Buzz Capital by Novamind. TORONTO, (GLOBE NEWSWIRE) - Buzz Capital Inc. Any failure to comply with this restriction may constitute a violation of U.S. Newswire Services or for dissemination in the United States.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |